Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersBreast cancer in the personal genomics eraGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskChallenging and complex decisions in the management of the BRCA mutation carrierFunctional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi originVariation in breast cancer risk in BRCA1 and BRCA2 mutation carriersEmergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumoursScreening for replication of genome-wide SNP associations in sporadic ALSRisk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudyBody mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genesRealizing the promise of cancer predisposition genes.Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes.Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.rs2981582 is associated with FGFR2 expression in normal breastCommon genetic variants and modification of penetrance of BRCA2-associated breast cancerExploring the link between germline and somatic genetic alterations in breast carcinogenesis.Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women.Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.Fine mapping of the 9q31 Hirschsprung's disease locus.Exploring the link between MORF4L1 and risk of breast cancer.BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriersGene-gene interactions in breast cancer susceptibility.Incorporating tumour pathology information into breast cancer risk prediction algorithms.Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.Identification of Novel Susceptibility Genes for Breast Cancer - Genome-Wide Association Studies or Evaluation of Candidate Genes?Breast cancer susceptibility: current knowledge and implications for genetic counsellingBreast Cancer Risk - Genes, Environment and Clinics.Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.Common low-penetrance risk variants associated with breast cancer in Polish women.Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) methodThe risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patientsFGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors.Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.The inherited genetics of ovarian and endometrial cancer.
P2860
Q21144874-C6DB11C8-5C3C-424B-BD2E-C694C12E031DQ24602679-9409BDB6-D92E-48D5-8651-7C825321B328Q27008356-7D1D7022-84DF-49C7-8C7E-A3D94ACD5CB7Q27026559-22A43F2C-8F47-456A-B52C-EBF4059BCE4DQ28260374-18FABA3A-B76D-4DBC-AC1C-D69025C0FEACQ28386156-383353B8-7F47-45D3-BF98-212F5FA1FB5CQ28609639-616EDBF3-6CFE-4860-B8F2-18D901B4C76BQ28943381-5E615E76-A04B-43CD-ACD4-8683A25A5020Q30426599-0EEB2F41-2474-43E3-B032-CD7F6AE92432Q30427359-B4AFCEA4-FF68-4F1B-A337-78B070E5FEE4Q30502502-715C9D18-DC49-49A5-86D6-D0895C8B26D4Q30743260-B2DC8F46-7294-4D3A-82AE-7E0F109B8AF1Q31159863-CB1FD4E6-E4FE-4B07-98AE-3EE63DACA926Q33394388-9A5DBE46-3EDF-4A39-B494-27B2134EE7DDQ33646928-61DD0382-978C-4201-B507-C579E4D38A7FQ33687533-75E6765E-F36F-4AE1-8E51-9EC70A8910A8Q33702141-DDB5E638-7116-46FE-8A35-633D4F005272Q33742096-8A3857A5-D121-4755-8521-6B59CFC043D4Q33761201-EA561DE5-BE6D-429E-8357-728F9EBD1905Q33835656-81208C3E-8E46-4748-A300-EFF16FCCA622Q33845209-306818CB-3C5A-43D2-9F7D-CB93C166D4BBQ33847327-25B78929-13DB-44B4-AF90-42766555F77FQ33853719-053153DB-D052-4D46-9D30-BE0999512609Q33863235-F5518DD7-C7F5-43FC-A0FD-EF3585465F1FQ33894431-11742944-9653-4607-BB17-98D58415C2A4Q33947829-7EB90280-CA58-4347-BCD7-3DA7D748B6E9Q34017597-DD2068DE-F1A1-4B4A-89EA-C6621E7B22EAQ34048046-DF73B27A-EC80-4E4C-AD1B-0F1EFFF27DC6Q34081324-72E84596-DEB7-4386-A064-D0E3BF4665C6Q34096129-CDA7D17C-E99E-4612-9C32-94212BD498AAQ34161642-10BBA1CC-082E-4FCF-973C-15107B8127FCQ34201805-3F37B296-EEA0-4022-89CF-104F438C1F4AQ34213403-EDE9C7E1-7C22-4FCD-9441-DEA24B29A7F2Q34394665-854C2A08-54B6-4B7E-9908-6C8F96D9794BQ34493797-FE4E757A-EBDF-4812-A969-9B1B9F39D61EQ34514962-E9DB8664-4F39-431C-999A-9DECEC67EAD7Q34523801-4B61A3AC-75F6-4B12-8FB0-79381E2A44A6Q34551122-AD49310B-A743-4B6D-B839-9CC7E4354515Q34613604-5C90002C-1627-4279-8BB2-939714A90258Q34775177-8C8DF705-99F3-4C96-B882-696330AA9A73
P2860
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@ast
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@en
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@nl
type
label
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@ast
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@en
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@nl
prefLabel
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@ast
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@en
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@nl
P2093
P2860
P50
P3181
P1476
Common breast cancer-predispos ...... A1 and BRCA2 mutation carriers
@en
P2093
Agnès Chompret
Andrew K Godwin
Ans M W van den Ouweland
Beatrix Versmold
Bella Kaufman
Christian Sutter
Claude Houdayer
Corinne Capoulade
Csilla I Szabo
P2860
P304
P3181
P356
10.1016/J.AJHG.2008.02.008
P407
P50
P577
2008-04-01T00:00:00Z